Skip to Main Content

Paper Details

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
Neoplasia
2
2023
CNS tumors, children, dinutuximab, pediatric, pediatric cancer, pediatric central nervous system (CNS) tumors, tumors
Author NameAffiliation
Jessica B FosterChildren's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
Marta M AlonsoUniversity Clinic of Navarra, Center for the Applied Medical Research (CIMA)
Marta M AlonsoUniversity Clinic of Navarra, Center for the Applied Medical Research (CIMA)
Tom B DavidsonCancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California
Matthew D DunSchool of Biomedical Sciences and Pharmacy, College of Health, University of Newcastle, Hunter Medical Research Institute, Australia Mark Hughes Foundation Centre for Brain Cancer Research
Cassie KlineChildren's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
Cassie KlineChildren's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
Sabine Mueller
Sabine Mueller
Nicholas A VitanzaBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle Children's Hospital, University of Washington
  • 1 - 10

Datasets